Roles of the NLRP3 inflammasome in the pathogenesis of diabetic nephropathy

Pharmacological Research

Volumn 114, Issue , 2016, Pages 251-264

  Qiu, Yuan ye ^a   Tang, Li qin ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Diabetic nephropathy; Inflammatory response; NLRP3 inflammasome; Pharmacological target; Regulation; Signalling pathway

Indexed keywords

CRYOPYRIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLAMMASOME; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; REACTIVE OXYGEN METABOLITE;

COMPLEX FORMATION; CYTOKINE RELEASE; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GENE EXPRESSION REGULATION; HUMAN; INFLAMMATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; IMMUNOLOGY; INNATE IMMUNITY; KIDNEY; PATHOLOGY; PATHOPHYSIOLOGY;

ANIMALS; DIABETIC NEPHROPATHIES; HUMANS; IMMUNITY, INNATE; INFLAMMASOMES; KIDNEY; NLR FAMILY, PYRIN DOMAIN-CONTAINING 3 PROTEIN; SIGNAL TRANSDUCTION;

EID: 84994834565     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2016.11.004     Document Type: Review

References (134)

1. [1] Chow, F., Ozols, E., Nikolic-Paterson, D.J., Atkins, R.C., Tesch, G.H., Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury. Kidney Int. 65 (2004), 116-128.
2. [2] Stolar, M., Glycemic control and complications in type 2 diabetes mellitus. Am. J. Med. 123 (2010), S3-S11.
3. [3] Wellen, K.E., Hotamisligil, G.S., Inflammation, stress, and diabetes. J. Clin. Invest. 115 (2005), 1111-1119.
4. [4] Fernandez-Real, J.M., Pickup, J.C., Innate immunity, insulin resistance and type 2 diabetes. Diabetologia 55 (2012), 273-278.
5. [5] Latz, E., Xiao, T.S., Stutz, A., Activation and regulation of the inflammasomes. Nat. Rev. Immunol. 13 (2013), 397-411.
6. [6] Zhang, C., Boini, K.M., Xia, M., Abais, J.M., Li, X., Liu, Q., Li, P.L., Activation of Nod-like receptor protein 3 inflammasomes turns on podocyte injury and glomerular sclerosis in hyperhomocysteinemia. Hypertension 60 (2012), 154-162.
7. [7] Halle, A., Hornung, V., Petzold, G.C., Stewart, C.R., Monks, B.G., Reinheckel, T., Fitzgerald, K.A., Latz, E., Moore, K.J., Golenbock, D.T., The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat. Immunol. 9 (2008), 857-865.
8. [8] Carneiro, L.A., Magalhaes, J.G., Tattoli, I., Philpott, D.J., Travassos, L.H., Nod-like proteins in inflammation and disease. J. Pathol. 214 (2008), 136-148.
9. [9] Inohara, Chamaillard, McDonald, C., Nunez, G., NOD-LRR proteins: role in host-microbial interactions and inflammatory disease. Annu. Rev. Biochem. 74 (2005), 355-383.
10. [10] Segovia, J., Sabbah, A., Mgbemena, V., Tsai, S.Y., Chang, T.H., Berton, M.T., Morris, I.R., Allen, I.C., Ting, J.P., Bose, S., TLR2/MyD88/NF-kappaB pathway, reactive oxygen species, potassium efflux activates NLRP3/ASC inflammasome during respiratory syncytial virus infection. PLoS One, 7, 2012, e29695.
11. [11] Stienstra, R., van Diepen, J.A., Tack, C.J., Zaki, M.H., van de Veerdonk, F.L., Perera, D., Neale, G.A., Hooiveld, G.J., Hijmans, A., Vroegrijk, I., van den Berg, S., Romijn, J., Rensen, P.C., Joosten, L.A., Netea, M.G., Kanneganti, T.D., Inflammasome is a central player in the induction of obesity and insulin resistance. Proc. Natl. Acad. Sci. U. S. A. 108 (2011), 15324-15329.
12. [12] Martinon, F., Burns, K., Tschopp, J., The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol. Cell 10 (2002), 417-426.
13. [13] Srinivasula, S.M., Poyet, J.L., Razmara, M., Datta, P., Zhang, Z., Alnemri, E.S., The PYRIN-CARD protein ASC is an activating adaptor for caspase-1. J. Biol. Chem. 277 (2002), 21119-21122.
14. [14] Lamkanfi, M., Dixit, V.M., Mechanisms and functions of inflammasomes. Cell 157 (2014), 1013-1022.
15. [15] Doria, A., Zen, M., Bettio, S., Gatto, M., Bassi, N., Nalotto, L., Ghirardello, A., Iaccarino, L., Punzi, L., Autoinflammation and autoimmunity: bridging the divide. Autoimmun. Rev. 12 (2012), 22-30.
16. [16] Gris, D., Ye, Z., Iocca, H.A., Wen, H., Craven, R.R., Gris, P., Huang, M., Schneider, M., Miller, S.D., Ting, J.P., NLRP3 plays a critical role in the development of experimental autoimmune encephalomyelitis by mediating Th1 and Th17 responses. J. Immunol. 185 (2010), 974-981.
17. [17] Kahlenberg, J.M., Kaplan, M.J., The inflammasome and lupus: another innate immune mechanism contributing to disease pathogenesis?. Curr. Opin. Rheumatol. 26 (2014), 475-481.
18. [18] Wen, H., Ting, J.P., O'Neill, L.A., A role for the NLRP3 inflammasome in metabolic diseases—did Warburg miss inflammation?. Nat. Immunol. 13 (2012), 352-357.
19. [19] Anders, H.J., Muruve, D.A., The inflammasomes in kidney disease. J. Am. Soc. Nephrol. 22 (2011), 1007-1018.
20. [20] Hutton, H.L., Ooi, J.D., Holdsworth, S.R., Kitching, A.R., The NLRP3 inflammasome in kidney disease and autoimmunity. Nephrology 21 (2016), 736-744.
21. [21] Abais, J.M., Zhang, C., Xia, M., Liu, Q., Gehr, T.W., Boini, K.M., Li, P.L., NADPH oxidase-mediated triggering of inflammasome activation in mouse podocytes and glomeruli during hyperhomocysteinemia. Antioxid. Redox. Signal. 18 (2013), 1537-1548.
22. [22] Lichtnekert, J., Kulkarni, O.P., Mulay, S.R., Rupanagudi, K.V., Ryu, M., Allam, R., Vielhauer, V., Muruve, D., Lindenmeyer, M.T., Cohen, C.D., Anders, H.J., Anti-GBM glomerulonephritis involves IL-1 but is independent of NLRP3/ASC inflammasome-mediated activation of caspase-1. PLoS One, 6, 2011, e26778.
23. [23] Wang, J., Wen, Y., Lv, L.L., Liu, H., Tang, R.N., Ma, K.L., Liu, B.C., Involvement of endoplasmic reticulum stress in angiotensin II-induced NLRP3 inflammasome activation in human renal proximal tubular cells in vitro. Acta Pharmacol. Sin. 36 (2015), 821-830.
24. [24] Zhou, R., Tardivel, A., Thorens, B., Choi, I., Tschopp, J., Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat. Immunol. 11 (2010), 136-140.
25. [25] Gauer, S., Sichler, O., Obermuller, N., Holzmann, Y., Kiss, E., Sobkowiak, E., Pfeilschifter, J., Geiger, H., Muhl, H., Hauser, I.A., IL-18 is expressed in the intercalated cell of human kidney. Kidney Int. 72 (2007), 1081-1087.
26. [26] Shahzad, K., Bock, F., Dong, W., Wang, H., Kopf, S., Kohli, S., Al-Dabet, M.M., Ranjan, S., Wolter, J., Wacker, C., Biemann, R., Stoyanov, S., Reymann, K., Soderkvist, P., Gross, O., Schwenger, V., Pahernik, S., Nawroth, P.P., Grone, H.J., Madhusudhan, T., Isermann, B., Nlrp3-inflammasome activation in non-myeloid-derived cells aggravates diabetic nephropathy. Kidney Int. 87 (2015), 74-84.
27. [27] Turner, M.D., Chaudhry, A., Nedjai, B., Tumour necrosis factor receptor trafficking dysfunction opens the TRAPS door to pro-inflammatory cytokine secretion. Biosci. Rep. 32 (2012), 105-112.
28. [28] Hao, J.L., Li, Y.F., Li, R.S., A novel mechanism of NALP3 inducing ischemia reperfusion injury by activating MAPK pathway in acute renal failure. Med. Hypotheses 80 (2013), 463-465.
29. [29] Terman, A., Kurz, T., Gustafsson, B., Brunk, U.T., Lysosomal labilization. IUBMB Life 58 (2006), 531-539.
30. [30] Taxman, D.J., Holley-Guthrie, E.A., Huang, M.T., Moore, C.B., Bergstralh, D.T., Allen, I.C., Lei, Y., Gris, D., Ting, J.P., The NLR adaptor ASC/PYCARD regulates DUSP10, mitogen-activated protein kinase (MAPK), and chemokine induction independent of the inflammasome. J. Biol. Chem. 286 (2011), 19605-19616.
31. [31] Tao, M., Scacheri, P.C., Marinis, J.M., Harhaj, E.W., Matesic, L.E., Abbott, D.W., ITCH K63-ubiquitinates the NOD2 binding protein, RIP2, to influence inflammatory signaling pathways. Curr. Biol. 19 (2009), 1255-1263.
32. [32] Johnson, G.L., Lapadat, R., Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298 (2002), 1911-1912.
33. [33] Liao, P.C., Chao, L.K., Chou, J.C., Dong, W.C., Lin, C.N., Lin, C.Y., Chen, A., Ka, S.M., Ho, C.L., Hua, K.F., Lipopolysaccharide/adenosine triphosphate-mediated signal transduction in the regulation of NLRP3 protein expression and caspase-1-mediated interleukin-1beta secretion. Inflamm. Res. 62 (2013), 89-96.
34. [34] Martinon, F., Detection of immune danger signals by NALP3. J. Leukoc. Biol. 83 (2008), 507-511.
35. [35] Ono, K., Han, J., The p38 signal transduction pathway: activation and function. Cell. Signal. 12 (2000), 1-13.
36. [36] Muller, R., Daniel, C., Hugo, C., Amann, K., Mielenz, D., Endlich, K., Braun, T., van der Veen, B., Heeringa, P., Schett, G., Zwerina, J., The mitogen-activated protein kinase p38alpha regulates tubular damage in murine anti-glomerular basement membrane nephritis. PLoS One, 8, 2013, e56316.
37. [37] Arthur, J.S., Ley, S.C., Mitogen-activated protein kinases in innate immunity. Nat. Rev. Immunol. 13 (2013), 679-692.
38. [38] Lee, J.K., Kim, S.H., Lewis, E.C., Azam, T., Reznikov, L.L., Dinarello, C.A., Differences in signaling pathways by IL-1beta and IL-18. Proc. Natl. Acad. Sci. U. S. A. 101 (2004), 8815-8820.
39. [39] Donnelly-Roberts, D.L., Namovic, M.T., Faltynek, C.R., Jarvis, M.F., Mitogen-activated protein kinase and caspase signaling pathways are required for P2X7 receptor (P2X7R)-induced pore formation in human THP-1 cells. J. Pharmacol. Exp. Ther. 308 (2004), 1053-1061.
40. [40] Rajamaki, K., Mayranpaa, M.I., Risco, A., Tuimala, J., Nurmi, K., Cuenda, A., Eklund, K.K., Oorni, K., Kovanen, P.T., p38delta MAPK: a novel regulator of NLRP3 inflammasome activation with increased expression in coronary atherogenesis. Arterioscler. Thromb. Vasc. Biol. 36 (2016), 1937-1946.
41. [41] Kang, S.W., Adler, S.G., Lapage, J., Natarajan, R., p38 MAPK and MAPK kinase 3/6 mRNA and activities are increased in early diabetic glomeruli. Kidney Int. 60 (2001), 543-552.
42. [42] Remy, G., Risco, A.M., Inesta-Vaquera, F.A., Gonzalez-Teran, B., Sabio, G., Davis, R.J., Cuenda, A., Differential activation of p38MAPK isoforms by MKK6 and MKK3. Cell. Signal. 22 (2010), 660-667.
43. [43] Polzer, K., Soleiman, A., Baum, W., Axmann, R., Distler, J., Redlich, K., Kilian, A., Kronke, G., Schett, G., Zwerina, J., Selective p38MAPK isoform expression and activation in antineutrophil cytoplasmatic antibody-associated crescentic glomerulonephritis: role of p38MAPKalpha. Ann. Rheum. Dis. 67 (2008), 602-608.
44. [44] Riad, A., Unger, D., Du, J., Westermann, D., Mohr, Z., Sobirey, M., Dorenkamp, M., Schultheiss, H.P., Tschope, C., Chronic inhibition of p38MAPK improves cardiac and endothelial function in experimental diabetes mellitus. Eur. J. Pharmacol. 554 (2007), 40-45.
45. [45] da Costa-Pessoa, J.M., Damasceno, R.S., Machado, U.F., Beloto-Silva, O., Oliveira-Souza, M., High glucose concentration stimulates NHE-1 activity in distal nephron cells: the role of the Mek/Erk1/2/p90RSK and p38MAPK signaling pathways. Cell Physiol. Biochem. 33 (2014), 333-343.
46. [46] Hsieh, T.J., Fustier, P., Zhang, S.L., Filep, J.G., Tang, S.S., Ingelfinger, J.R., Fantus, I.G., Hamet, P., Chan, J.S., High glucose stimulates angiotensinogen gene expression and cell hypertrophy via activation of the hexosamine biosynthesis pathway in rat kidney proximal tubular cells. Endocrinology 144 (2003), 4338-4349.
47. [47] Burt, D.J., Gruden, G., Thomas, S.M., Tutt, P., Dell'Anna, C., Viberti, G.C., Gnudi, L., P38 mitogen-activated protein kinase mediates hexosamine-induced TGFbeta1 mRNA expression in human mesangial cells. Diabetologia 46 (2003), 531-537.
48. [48] Susztak, K., Raff, A.C., Schiffer, M., Bottinger, E.P., Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. Diabetes 55 (2006), 225-233.
49. [49] Kang, S.W., Natarajan, R., Shahed, A., Nast, C.C., LaPage, J., Mundel, P., Kashtan, C., Adler, S.G., Role of 12-lipoxygenase in the stimulation of p38 mitogen-activated protein kinase and collagen alpha5(IV) in experimental diabetic nephropathy and in glucose-stimulated podocytes. J. Am. Soc. Nephrol. 14 (2003), 3178-3187.
50. [50] Dai, T., Natarajan, R., Nast, C.C., LaPage, J., Chuang, P., Sim, J., Tong, L., Chamberlin, M., Wang, S., Adler, S.G., Glucose and diabetes: effects on podocyte and glomerular p38MAPK, heat shock protein 25, and actin cytoskeleton. Kidney Int. 69 (2006), 806-814.
51. [51] Deshpande, S.D., Putta, S., Wang, M., Lai, J.Y., Bitzer, M., Nelson, R.G., Lanting, L.L., Kato, M., Natarajan, R., Transforming growth factor-beta-induced cross talk between p53 and a microRNA in the pathogenesis of diabetic nephropathy. Diabetes 62 (2013), 3151-3162.
52. [52] Chen, H.L., Wan, Y.G., Zhao, Q., Huang, Y.R., Shi, X.M., Meng, X.J., Yao, J., Regulative mechanism of renal inflammatory-related p38MAPK signaling pathway in diabetic nephropathy and interventional effects of Chinese herbal medicine. Zhongguo Zhong Yao Za Zhi 38 (2013), 2268-2272.
53. [53] Navarro-Gonzalez, J.F., Mora-Fernandez, C., The role of inflammatory cytokines in diabetic nephropathy. J. Am. Soc. Nephrol. 19 (2008), 433-442.
54. [54] Zhao, Q., Wan, Y., Wang, C., Wei, Q., Chen, H., Meng, X., Yao, J., Regulatory mechanism of p38MAPK signaling pathway on renal tissue inflammation in chronic kidney disease and interventional effect of traditional Chinese medicine. Zhongguo Zhong Yao Za Zhi 37 (2012), 1700-1704.
55. [55] Lorenz, G., Darisipudi, M.N., Anders, H.J., Canonical and non-canonical effects of the NLRP3 inflammasome in kidney inflammation and fibrosis. Nephrol. Dial. Transplant. 29 (2014), 41-48.
56. [56] Wang, W., Wang, X., Chun, J., Vilaysane, A., Clark, S., French, G., Bracey, N.A., Trpkov, K., Bonni, S., Duff, H.J., Beck, P.L., Muruve, D.A., Inflammasome-independent NLRP3 augments TGF-beta signaling in kidney epithelium. J. Immunol. 190 (2013), 1239-1249.
57. [57] Niemir, Z.I., Stein, H., Dworacki, G., Mundel, P., Koehl, N., Koch, B., Autschbach, F., Andrassy, K., Ritz, E., Waldherr, R., Otto, H.F., Podocytes are the major source of IL-1 alpha and IL-1 beta in human glomerulonephritides. Kidney Int. 52 (1997), 393-403.
58. [58] Karrasch, T., Steinbrecher, K.A., Allard, B., Baldwin, A.S., Jobin, C., Wound-induced p38MAPK-dependent histone H3 phosphorylation correlates with increased COX-2 expression in enterocytes. J. Cell Physiol. 207 (2006), 809-815.
59. [59] He, Q., You, H., Li, X.M., Liu, T.H., Wang, P., Wang, B.E., HMGB1 promotes the synthesis of pro-IL-1beta and pro-IL-18 by activation of p38 MAPK and NF-kappaB through receptors for advanced glycation end-products in macrophages. Asian Pac. J. Cancer Prev. 13 (2012), 1365-1370.
60. [60] Price, D.M., Wloka, M.T., Chik, C.L., Ho, A.K., Mitogen-activated protein kinase phosphatase-1 (MKP-1) preferentially dephosphorylates p42/44MAPK but not p38MAPK in rat pinealocytes. J. Neurochem. 101 (2007), 1685-1693.
61. [61] Meloche, S., Pouyssegur, J., The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition. Oncogene 26 (2007), 3227-3239.
62. [62] Kanwar, Y.S., Wada, J., Sun, L., Xie, P., Wallner, E.I., Chen, S., Chugh, S., Danesh, F.R., Diabetic nephropathy: mechanisms of renal disease progression. Exp. Biol. Med. 233 (2008), 4-11.
63. [63] Sakai, N., Wada, T., Furuichi, K., Iwata, Y., Yoshimoto, K., Kitagawa, K., Kokubo, S., Kobayashi, M., Hara, A., Yamahana, J., Okumura, T., Takasawa, K., Takeda, S., Yoshimura, M., Kida, H., Yokoyama, H., Involvement of extracellular signal-regulated kinase and p38 in human diabetic nephropathy. Am. J. Kidney Dis. 45 (2005), 54-65.
64. [64] O'Neill, L.A., Immunology. How frustration leads to inflammation. Science 320 (2008), 619-620.
65. [65] Tschopp, J., Schroder, K., NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production?. Nat. Rev. Immunol. 10 (2010), 210-215.
66. [66] Ghonime, M.G., Shamaa, O.R., Das, S., Eldomany, R.A., Fernandes-Alnemri, T., Alnemri, E.S., Gavrilin, M.A., Wewers, M.D., Inflammasome priming by lipopolysaccharide is dependent upon ERK signaling and proteasome function. J. Immunol. 192 (2014), 3881-3888.
67. [67] Toyoda, M., Suzuki, D., Honma, M., Uehara, G., Sakai, T., Umezono, T., Sakai, H., High expression of PKC-MAPK pathway mRNAs correlates with glomerular lesions in human diabetic nephropathy. Kidney Int. 66 (2004), 1107-1114.
68. [68] Hoshi, S., Nomoto, K., Kuromitsu, J., Tomari, S., Nagata, M., High glucose induced VEGF expression via PKC and ERK in glomerular podocytes. Biochem. Biophys. Res. Commun. 290 (2002), 177-184.
69. [69] Akira, S., Takeda, K., Toll-like receptor signalling. Nat. Rev. Immunol. 4 (2004), 499-511.
70. [70] Budai, M.M., Varga, A., Milesz, S., Tozser, J., Benko, S., Aloe vera downregulates LPS-induced inflammatory cytokine production and expression of NLRP3 inflammasome in human macrophages. Mol. Immunol. 56 (2013), 471-479.
71. [71] Bauernfeind, F.G., Horvath, G., Stutz, A., Alnemri, E.S., MacDonald, K., Speert, D., Fernandes-Alnemri, T., Wu, J., Monks, B.G., Fitzgerald, K.A., Hornung, V., Latz, E., Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J. Immunol. 183 (2009), 787-791.
72. [72] Hsu, H.Y., Wen, M.H., Lipopolysaccharide-mediated reactive oxygen species and signal transduction in the regulation of interleukin-1 gene expression. J. Biol. Chem. 277 (2002), 22131-22139.
73. [73] Long, D.A., Price, K.L., Herrera-Acosta, J., Johnson, R.J., How does angiotensin II cause renal injury?. Hypertension 43 (2004), 722-723.
74. [74] Hedl, M., Abraham, C., Nod2-induced autocrine interleukin-1 alters signaling by ERK and p38 to differentially regulate secretion of inflammatory cytokines. Gastroenterology 143 (2012), 1530-1543.
75. [75] Wan-Xin, T., Tian-Lei, C., Ben, W., Wei-Hua, W., Ping, F., Effect of mitofusin 2 overexpression on the proliferation and apoptosis of high-glucose-induced rat glomerular mesangial cells. J. Nephrol. 25 (2012), 1023-1030.
76. [76] Twigg, S.M., Mastering a mediator: blockade of CCN-2 shows early promise in human diabetic kidney disease. J. Cell Commun. Signal. 4 (2010), 189-196.
77. [77] Guo, Y., Yuan, W., Wang, L., Shang, M., Peng, Y., Parathyroid hormone-potentiated connective tissue growth factor expression in human renal proximal tubular cells through activating the MAPK and NF-kappaB signalling pathways. Nephrol. Dial. Transplant. 26 (2011), 839-847.
78. [78] Yang, W.S., Chang, J.W., Han, N.J., Lee, S.K., Park, S.K., Spleen tyrosine kinase mediates high glucose-induced transforming growth factor-beta1 up-regulation in proximal tubular epithelial cells. Exp. Cell Res. 318 (2012), 1867-1876.
79. [79] Tang, S.C., Lai, K.N., The pathogenic role of the renal proximal tubular cell in diabetic nephropathy. Nephrol. Dial. Transplant. 27 (2012), 3049-3056.
80. [80] Okada, M., Matsuzawa, A., Yoshimura, A., Ichijo, H., The lysosome rupture-activated TAK1-JNK pathway regulates NLRP3 inflammasome activation. J. Biol. Chem. 289 (2014), 32926-32936.
81. [81] Takekawa, M., Tatebayashi, K., Saito, H., Conserved docking site is essential for activation of mammalian MAP kinase kinases by specific MAP kinase kinase kinases. Mol. Cell 18 (2005), 295-306.
82. [82] McDonald, P.H., Chow, C.W., Miller, W.E., Laporte, S.A., Field, M.E., Lin, F.T., Davis, R.J., Lefkowitz, R.J., Beta-arrestin 2: a receptor-regulated MAPK scaffold for the activation of JNK3. Science 290 (2000), 1574-1577.
83. [83] Hasegawa, M., Imamura, R., Motani, K., Nishiuchi, T., Matsumoto, N., Kinoshita, T., Suda, T., Mechanism and repertoire of ASC-mediated gene expression. J. Immunol. 182 (2009), 7655-7662.
84. [84] Banerjee, A., Gerondakis, S., Coordinating TLR-activated signaling pathways in cells of the immune system. Immunol. Cell Biol. 85 (2007), 420-424.
85. [85] Yang, R., Trevillyan, J.M., c-Jun N-terminal kinase pathways in diabetes. Int. J. Biochem. Cell Biol. 40 (2008), 2702-2706.
86. [86] Mirza, R.E., Fang, M.M., Weinheimer-Haus, E.M., Ennis, W.J., Koh, T.J., Sustained inflammasome activity in macrophages impairs wound healing in type 2 diabetic humans and mice. Diabetes 63 (2014), 1103-1114.
87. [87] Forbes, J.M., Coughlan, M.T., Cooper, M.E., Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes 57 (2008), 1446-1454.
88. [88] Nishikawa, T., Edelstein, D., Du, X.L., Yamagishi, S.-i., Matsumura, T., Kaneda, Y., Yorek, M.A., Beebe, D., Oates, P.J., Hammes, H.-P., Giardino, I., Brownlee, M., Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404 (2000), 787-790.
89. [89] Rosca, M.G., Mustata, T.G., Kinter, M.T., Ozdemir, A.M., Kern, T.S., Szweda, L.I., Brownlee, M., Monnier, V.M., Weiss, M.F., Glycation of mitochondrial proteins from diabetic rat kidney is associated with excess superoxide formation. Am. J. Physiol. Renal Physiol. 289 (2005), F420-F430.
90. [90] Ogier-Denis, E., Mkaddem, S.B., Vandewalle, A., NOX enzymes and toll-like receptor signaling. Semin. Immunopathol. 30 (2008), 291-300.
91. [91] Iriti, M., Faoro, F., Review of innate and specific immunity in plants and animals. Mycopathologia 164 (2007), 57-64.
92. [92] Martinon, F., Mayor, A., Tschopp, J., The inflammasomes: guardians of the body. Annu. Rev. Immunol. 27 (2009), 229-265.
93. [93] Petrilli, V., Papin, S., Dostert, C., Mayor, A., Martinon, F., Tschopp, J., Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration. Cell. Death Differ. 14 (2007), 1583-1589.
94. [94] Fay, A.J., Qian, X., Jan, Y.N., Jan, L.Y., SK channels mediate NADPH oxidase-independent reactive oxygen species production and apoptosis in granulocytes. Proc. Natl. Acad. Sci. U. S. A. 103 (2006), 17548-17553.
95. [95] Dostert, C., Petrilli, V., Van Bruggen, R., Steele, C., Mossman, B.T., Tschopp, J., Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 320 (2008), 674-677.
96. [96] Cruz, C.M., Rinna, A., Forman, H.J., Ventura, A.L., Persechini, P.M., Ojcius, D.M., ATP activates a reactive oxygen species-dependent oxidative stress response and secretion of proinflammatory cytokines in macrophages. J. Biol. Chem. 282 (2007), 2871-2879.
97. [97] Parikh, H., Carlsson, E., Chutkow, W.A., Johansson, L.E., Storgaard, H., Poulsen, P., Saxena, R., Ladd, C., Schulze, P.C., Mazzini, M.J., Jensen, C.B., Krook, A., Bjornholm, M., Tornqvist, H., Zierath, J.R., Ridderstrale, M., Altshuler, D., Lee, R.T., Vaag, A., Groop, L.C., Mootha, V.K., TXNIP regulates peripheral glucose metabolism in humans. PLoS Med., 4, 2007, e158.
98. [98] van Greevenbroek, M.M., Vermeulen, V.M., Feskens, E.J., Evelo, C.T., Kruijshoop, M., Hoebee, B., van der Kallen, C.J., de Bruin, T.W., Genetic variation in thioredoxin interacting protein (TXNIP) is associated with hypertriglyceridaemia and blood pressure in diabetes mellitus. Diabet. Med. 24 (2007), 498-504.
99. [99] Fitzgerald, K.A., NLR-containing inflammasomes: central mediators of host defense and inflammation. Eur. J. Immunol. 40 (2010), 595-598.
100. [100] Jiang, W., Li, M., He, F., Yao, W., Bian, Z., Wang, X., Zhu, L., Protective effects of asiatic acid against spinal cord injury-induced acute lung injury in rats. Inflammation, 2016, 10.1007/s10753-016-0414-3.
101. [101] Fernandes-Alnemri, T., Wu, J., Yu, J.W., Datta, P., Miller, B., Jankowski, W., Rosenberg, S., Zhang, J., Alnemri, E.S., The pyroptosome: a supramolecular assembly of ASC dimers mediating inflammatory cell death via caspase-1 activation. Cell Death Differ. 14 (2007), 1590-1604.
102. [102] Mora, C., Navarro, J.F., Inflammation and diabetic nephropathy. Curr. Diab. Rep. 6 (2006), 463-468.
103. [103] Martinon, F., Signaling by ROS drives inflammasome activation. Eur. J. Immunol. 40 (2010), 616-619.
104. [104] Bauernfeind, F., Bartok, E., Rieger, A., Franchi, L., Nunez, G., Hornung, V., Cutting edge: reactive oxygen species inhibitors block priming, but not activation, of the NLRP3 inflammasome. J. Immunol. 187 (2011), 613-617.
105. [105] Navarro-Gonzalez, J.F., Mora-Fernandez, C., Muros de Fuentes, M., Garcia-Perez, J., Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy. Nat. Rev. Nephrol. 7 (2011), 327-340.
106. [106] Li, Y., Wang, S., Glycated albumin activates NADPH oxidase in rat mesangial cells through up-regulation of p47phox. Biochem. Biophys. Res. Commun. 397 (2010), 5-11.
107. [107] Lee, E.A., Seo, J.Y., Jiang, Z., Yu, M.R., Kwon, M.K., Ha, H., Lee, H.B., Reactive oxygen species mediate high glucose-induced plasminogen activator inhibitor-1 up-regulation in mesangial cells and in diabetic kidney. Kidney Int. 67 (2005), 1762-1771.
108. [108] Prabhakar, S., Starnes, J., Shi, S., Lonis, B., Tran, R., Diabetic nephropathy is associated with oxidative stress and decreased renal nitric oxide production. J. Am. Soc. Nephrol. 18 (2007), 2945-2952.
109. [109] Xu, M., Dai, D.Z., Dai, Y., Normalizing NADPH oxidase contributes to attenuating diabetic nephropathy by the dual endothelin receptor antagonist CPU0213 in rats. Am. J. Nephrol. 29 (2009), 252-256.
110. [110] Tumur, Z., Shimizu, H., Enomoto, A., Miyazaki, H., Niwa, T., Indoxyl sulfate upregulates expression of ICAM-1 and MCP-1 by oxidative stress-induced NF-kappaB activation. Am. J. Nephrol. 31 (2010), 435-441.
111. [111] Jiang, Q., Liu, P., Wu, X., Liu, W., Shen, X., Lan, T., Xu, S., Peng, J., Xie, X., Huang, H., Berberine attenuates lipopolysaccharide-induced extracelluar matrix accumulation and inflammation in rat mesangial cells: involvement of NF-kappaB signaling pathway. Mol. Cell. Endocrinol. 331 (2011), 34-40.
112. [112] Allen, I.C., TeKippe, E.M., Woodford, R.M., Uronis, J.M., Holl, E.K., Rogers, A.B., Herfarth, H.H., Jobin, C., Ting, J.P., The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer. J. Exp. Med. 207 (2010), 1045-1056.
113. [113] Zaki, M.H., Vogel, P., Body-Malapel, M., Lamkanfi, M., Kanneganti, T.D., IL-18 production downstream of the Nlrp3 inflammasome confers protection against colorectal tumor formation. J. Immunol. 185 (2010), 4912-4920.
114. [114] Samra, Y.A., Said, H.S., Elsherbiny, N.M., Liou, G.I., El-Shishtawy, M.M., Eissa, L.A., Cepharanthine and Piperine ameliorate diabetic nephropathy in rats: role of NF-kappaB and NLRP3 inflammasome. Life Sci. 157 (2016), 187-199.
115. [115] Huang, W., Xu, L., Zhou, X., Gao, C., Yang, M., Chen, G., Zhu, J., Jiang, L., Gan, H., Gou, F., Feng, H., Peng, J., Xu, Y., High glucose induces activation of NF-kappaB inflammatory signaling through IkappaBalpha sumoylation in rat mesangial cells. Biochem. Biophys. Res. Commun. 438 (2013), 568-574.
116. [116] Yang, Y., Xia, F., Hermance, N., Mabb, A., Simonson, S., Morrissey, S., Gandhi, P., Munson, M., Miyamoto, S., Kelliher, M.A., A cytosolic ATM/NEMO/RIP1 complex recruits TAK1 to mediate the NF-kappaB and p38 mitogen-activated protein kinase (MAPK)/MAPK-activated protein 2 responses to DNA damage. Mol. Cell. Biol. 31 (2011), 2774-2786.
117. [117] Yang, J., Zeng, Z., Wu, T., Yang, Z., Liu, B., Lan, T., Emodin attenuates high glucose-induced TGF-beta1 and fibronectin expression in mesangial cells through inhibition of NF-kappaB pathway. Exp. Cell Res. 319 (2013), 3182-3189.
118. [118] Yang, S.M., Ka, S.M., Wu, H.L., Yeh, Y.C., Kuo, C.H., Hua, K.F., Shi, G.Y., Hung, Y.J., Hsiao, F.C., Yang, S.S., Shieh, Y.S., Lin, S.H., Wei, C.W., Lee, J.S., Yang, C.Y., Chen, A., Thrombomodulin domain 1 ameliorates diabetic nephropathy in mice via anti-NF-kappaB/NLRP3 inflammasome-mediated inflammation, enhancement of NRF2 antioxidant activity and inhibition of apoptosis. Diabetologia 57 (2014), 424-434.
119. [119] Wang, C., Pan, Y., Zhang, Q.Y., Wang, F.M., Kong, L.D., Quercetin and allopurinol ameliorate kidney injury in STZ-treated rats with regulation of renal NLRP3 inflammasome activation and lipid accumulation. PLoS One, 7, 2012, e38285.
120. [120] Gasse, P., Riteau, N., Charron, S., Girre, S., Fick, L., Petrilli, V., Tschopp, J., Lagente, V., Quesniaux, V.F., Ryffel, B., Couillin, I., Uric acid is a danger signal activating NALP3 inflammasome in lung injury inflammation and fibrosis. Am. J. Respir. Crit. Care Med. 179 (2009), 903-913.
121. [121] Larsen, C.M., Faulenbach, M., Vaag, A., Volund, A., Ehses, J.A., Seifert, B., Mandrup-Poulsen, T., Donath, M.Y., Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N. Engl. J. Med. 356 (2007), 1517-1526.
122. [122] Brady, H.R., Leukocyte adhesion molecules and kidney diseases. Kidney Int. 45 (1994), 1285-1300.
123. [123] Park, C.W., Kim, J.H., Lee, J.H., Kim, Y.S., Ahn, H.J., Shin, Y.S., Kim, S.Y., Choi, E.J., Chang, Y.S., Bang, B.K., High glucose-induced intercellular adhesion molecule-1 (ICAM-1) expression through an osmotic effect in rat mesangial cells is PKC-NF-kappa B-dependent. Diabetologia 43 (2000), 1544-1553.
124. [124] Jones, S., Jones, S., Phillips, A.O., Regulation of renal proximal tubular epithelial cell hyaluronan generation: implications for diabetic nephropathy. Kidney Int. 59 (2001), 1739-1749.
125. [125] Awad, A.S., Kinsey, G.R., Khutsishvili, K., Gao, T., Bolton, W.K., Okusa, M.D., Monocyte/macrophage chemokine receptor CCR2 mediates diabetic renal injury. Am. J. Physiol. Renal Physiol. 301 (2011), F1358-F1366.
126. [126] Kusuhara, M., Isoda, K., Ohsuzu, F., Interleukin-1 and occlusive arterial diseases. Cardiovasc. Hematol. Agents Med. Chem. 4 (2006), 229-235.
127. [127] So, A., De Smedt, T., Revaz, S., Tschopp, J., A pilot study of IL-1 inhibition by anakinra in acute gout. Arthritis Res. Ther., 9, 2007, R28.
128. [128] McGonagle, D., Tan, A.L., Shankaranarayana, S., Madden, J., Emery, P., McDermott, M.F., Management of treatment resistant inflammation of acute on chronic tophaceous gout with anakinra. Ann. Rheum. Dis. 66 (2007), 1683-1684.
129. [129] Araki, S., Haneda, M., Koya, D., Sugimoto, T., Isshiki, K., Chin-Kanasaki, M., Uzu, T., Kashiwagi, A., Predictive impact of elevated serum level of IL-18 for early renal dysfunction in type 2 diabetes: an observational follow-up study. Diabetologia 50 (2007), 867-873.
130. [130] Martinez, G.J., Robertson, S., Barraclough, J., Xia, Q., Mallat, Z., Bursill, C., Celermajer, D.S., Patel, S., Colchicine acutely suppresses local cardiac production of inflammatory cytokines in patients with an acute coronary syndrome. J. Am. Heart Assoc., 4, 2015, e002128.
131. [131] Carta, S., Penco, F., Lavieri, R., Martini, A., Dinarello, C.A., Gattorno, M., Rubartelli, A., Cell stress increases ATP release in NLRP3 inflammasome-mediated autoinflammatory diseases, resulting in cytokine imbalance. Proc. Natl. Acad. Sci. U. S. A. 112 (2015), 2835-2840.
132. [132] Schroder, K., Zhou, R., Tschopp, J., The NLRP3 inflammasome: a sensor for metabolic danger?. Science 327 (2010), 296-300.
133. [133] Satoh, M., Tabuchi, T., Itoh, T., Nakamura, M., NLRP3 inflammasome activation in coronary artery disease: results from prospective and randomized study of treatment with atorvastatin or rosuvastatin. Clin. Sci. 126 (2014), 233-241.
134. [134] Nakamura, A., Shikata, K., Hiramatsu, M., Nakatou, T., Kitamura, T., Wada, J., Itoshima, T., Makino, H., Serum interleukin-18 levels are associated with nephropathy and atherosclerosis in Japanese patients with type 2 diabetes. Diabetes Care 28 (2005), 2890-2895.